Literature DB >> 21081168

Crystal structure of FabG4 from Mycobacterium tuberculosis reveals the importance of C-terminal residues in ketoreductase activity.

Debajyoti Dutta1, Sudipta Bhattacharyya, Somnath Mukherjee, Baisakhee Saha, Amit Kumar Das.   

Abstract

Rv0242c, also known as FabG4, is a beta-ketoacyl CoA reductase in Mycobacterium tuberculosis. The crystal structure of C-terminal truncated FabG4 is solved at 2.5Å resolution which shows the presence of two distinct domains, domain I and II. Domain I partially resembles "flavodoxin type domain" and the domain II is a typical "ketoacyl CoA reductase (KAR) domain". The enzyme exhibits ketoacyl CoA reductase activity by reducing acetoacyl CoA to 3-hydroxyacyl CoA in presence of NADH. Conserved catalytic triad Ser347, Tyr360, and Lys364 constitute the active site residues of the KAR domain. Presence of the Tyr and the Lys residues in the triad in a particular orientation is imperative for effective catalytic mechanism. The importance of loop I and II and the role of the C-terminal residues of KAR domain are highlighted. Comparative structural analyses clearly demonstrate that loop II is stabilized by hydrophobic interaction with C-terminal residues to sustain the orientation of Tyr360. Loop I interacts with loop II via H-bonding network to restrict the active site residue Lys364 in a catalytically favorable orientation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081168     DOI: 10.1016/j.jsb.2010.11.012

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  7 in total

1.  Crystallization and preliminary X-ray diffraction analysis of the high molecular weight ketoacyl reductase FabG4 complexed with NADH.

Authors:  Debajyoti Dutta; Sudipta Bhattacharyya; Amit Kumar Das
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-06-27

2.  Cloning, overexpression, purification, crystallization and preliminary X-ray diffraction analysis of Rv0241c (HtdX) from Mycobacterium tuberculosis H37Rv.

Authors:  Rupam Biswas; Debajyoti Dutta; Amit Kumar Das
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-09-28

3.  Dissecting the Structural Elements for the Activation of β-Ketoacyl-(Acyl Carrier Protein) Reductase from Vibrio cholerae.

Authors:  Jing Hou; Heping Zheng; Maksymilian Chruszcz; Matthew D Zimmerman; Igor A Shumilin; Tomasz Osinski; Matt Demas; Sarah Grimshaw; Wladek Minor
Journal:  J Bacteriol       Date:  2015-11-09       Impact factor: 3.490

4.  S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope.

Authors:  Padam Singh; Shashi Kant Kumar; Vineet Kumar Maurya; Basant Kumar Mehta; Hafsa Ahmad; Anil Kumar Dwivedi; Vinita Chaturvedi; Tejender S Thakur; Sudhir Sinha
Journal:  ACS Omega       Date:  2017-11-30

5.  Advance in Research on Mycobacterium tuberculosis FabG4 and Its Inhibitor.

Authors:  Debajyoti Dutta
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

6.  Insights into Acinetobacter baumannii fatty acid synthesis 3-oxoacyl-ACP reductases.

Authors:  Emily M Cross; Felise G Adams; Jack K Waters; David Aragão; Bart A Eijkelkamp; Jade K Forwood
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

7.  Structural Characterisation of FabG from Yersinia pestis, a Key Component of Bacterial Fatty Acid Synthesis.

Authors:  Jeffrey D Nanson; Jade K Forwood
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.